HIV and ID Observations

April 27th, 2014

Why ID/HIV Specialists Rank Last in MD Salaries

Here’s a figure from Medscape listing 2013 physician compensation: Now a median of $174,000/year is hardly chump change, so I don’t expect much in the way of sympathy on these data. On the other hand, someone has to to be last, and note that our income hasn’t increased a bit since the last time I […]

---

April 24th, 2014

Pioneering Measles Vaccine Researcher Has Anecdotes, Insight, Perspective, and Generosity to Spare

In the new IDSA/Oxford University Press journal Open Forum Infectious Diseases (OFID), we plan to interview a series of great figures in ID about their experiences, posting them as podcasts with accompanying scripts. Our first interview is with Dr. Samuel Katz, a key figure in development of the measles vaccine, and it can be heard […]

---

April 12th, 2014

Unwittingly, HCV “News” Brackets Our Current Treatment Era on Successive Days

I’ve already told you what a fan I am of Physician’s First Watch, the daily email summary of hot medical news provided by my colleagues here at the Massachusetts Medical Society. If you haven’t signed up, you must do so — let’s play a short tune (always a favorite) for background music while you head […]

---

April 8th, 2014

Would “HIV Controllers” Benefit from Antiretroviral Therapy?

Let me start with a disclosure — I’m the co-PI (along with Jon Li and Florencia Pereyra) on a study addressing the very question in the title. The reason for this post is that the topic has been the beneficiary of some terrific coverage in Nature Medicine, both of this research question specifically and the whole topic […]

---

April 5th, 2014

$0 for 30 Minutes of My Time? Sign Me Up!

Best e-mail survey ever, my second invitation from them — hence a “friendly reminder”: Dear Sax, This is a friendly reminder about the online study we recently invited you to – X5328963_HCV Approximate interview length: 30 minutes Honorarium: $0 Estimated end date: 2014.06.22 By clicking the survey link below, you agree to participate under the […]

---